At 34, Vivek Ramaswamy, founder and CEO of Roivant Sciences, is already a top leader in biotech. In Roivant, he has created a unique company comprising nearly 20 “vants” — entrepreneurial biotech and healthcare technology companies — that together boast  a diverse pipeline of more that 45 investigational drugs in 14 therapeutic areas. In this Dialogue, he shares his (somewhat provocative) thoughts — and speaks to participants' questions and comments — on the responsibilities of corporations in times of crisis.

The conversation is part of an ongoing series of Vanguard Leadership Dialogues with top leaders about "Leading Through Uncertainty." New sessions are held approximately every two weeks for participating audiences of senior executives; to learn more or register for an upcoming session, click here.